Russia: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

Russia: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Russia: Sputnik V – “the first registered COVID-19 vaccine”
https://sputnikvaccine.com/newsroom/pressreleases/
Press Releases
Sputnik V vaccine against coronavirus authorized in Nigeria
Press release, 15.07.2021

Single-dose Sputnik Light vaccine registered in Kazakhstan
Press release, 15.07.2021

RDIF and Serum Institute of India, the world’s largest vaccine manufacturer by volume, to start production of Sputnik vaccine at Company’s facilities in September
Press release, 13.07.2021
Technology transfer process has already started; cultivation process has begun following the approval by the Drug Controller General of India (DCGI).
The parties intend to produce over 300 million doses of the vaccine in India per year with the first batch expected in September 2021.
Moscow, July 13, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, today announced cooperation to produce the Russian Sputnik vaccine against coronavirus.
SII is the world’s largest company in terms of COVID vaccines production with over 500 million doses manufactured. Through several strategic associations, SII has been front running India’s fight against the pandemic. In addition to developing its own vaccine, it is currently manufacturing Covishield (developed by AstraZeneca-Oxford), Covovax (by Novavax) and conducting trials of Codagenix in UK.
The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September. The parties intend to produce over 300 million doses of the vaccine in India per year…

Sputnik V vaccine effective against new variants of coronavirus, the Gamaleya Center study published in Vaccines leading international journal, shows
Press release, 12.07.2021

Sputnik V vaccine elicits high IGG antibodies and neutralizing antibodies titers, a study in Argentina published in international Cell Reports Medicine journal shows
Press release, 12.07.2021

Sputnik V vaccine demonstrates strong safety profile during vaccination campaign in San Marino
Press release, 11.07.2021